Global (United States, European Union and China) Acquired hemophilia A Treatment Market Research Report 2019-2025

Choose License

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
In 2019, the market size of Acquired hemophilia A Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acquired hemophilia A Treatment. 

This report studies the global market size of Acquired hemophilia A Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). 
This study presents the Acquired hemophilia A Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. 
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
    Sanofi
    ...

Market Segment by Product Type
    200IU
    250IU

Market Segment by Application
    Hospital
    Pharmacy

Key Regions split in this report: breakdown data for each region.
    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
    To analyze and research the Acquired hemophilia A Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Acquired hemophilia A Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications 
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Acquired hemophilia A Treatment are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Major Manufacturers Covered in This Report
    1.3 Market Segment by Type
        1.3.1 Global Acquired hemophilia A Treatment Market Size Growth Rate by Type (2019-2025)
        1.3.2 200IU
        1.3.3 250IU
    1.4 Market Segment by Application
        1.4.1 Global Acquired hemophilia A Treatment Market Share by Application (2019-2025)
        1.4.2 Hospital
        1.4.3 Pharmacy
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Acquired hemophilia A Treatment Market Size
        2.1.1 Global Acquired hemophilia A Treatment Revenue 2014-2025
        2.1.2 Global Acquired hemophilia A Treatment Sales 2014-2025
    2.2 Acquired hemophilia A Treatment Growth Rate by Regions
        2.2.1 Global Acquired hemophilia A Treatment Sales by Regions 2014-2019
        2.2.2 Global Acquired hemophilia A Treatment Revenue by Regions 2014-2019
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers

3 Market Share by Manufacturers
    3.1 Acquired hemophilia A Treatment Sales by Manufacturers
        3.1.1 Acquired hemophilia A Treatment Sales by Manufacturers 2014-2019
        3.1.2 Acquired hemophilia A Treatment Sales Market Share by Manufacturers 2014-2019
    3.2 Revenue by Manufacturers
        3.2.1 Acquired hemophilia A Treatment Revenue by Manufacturers (2014-2019)
        3.2.2 Acquired hemophilia A Treatment Revenue Share by Manufacturers (2014-2019)
        3.2.3 Global Acquired hemophilia A Treatment Market Concentration Ratio (CR5 and HHI)
    3.3 Acquired hemophilia A Treatment Price by Manufacturers
    3.4 Key Manufacturers Acquired hemophilia A Treatment Plants/Factories Distribution and Area Served
    3.5 Date of Key Manufacturers Enter into Acquired hemophilia A Treatment Market
    3.6 Key Manufacturers Acquired hemophilia A Treatment Product Offered
    3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Sales and Revenue for Each Type
        4.1.1 200IU Sales and Revenue (2014-2019)
        4.1.2 250IU Sales and Revenue (2014-2019)
    4.2 Global Acquired hemophilia A Treatment Sales Market Share by Type
    4.3 Global Acquired hemophilia A Treatment Revenue Market Share by Type
    4.4 Acquired hemophilia A Treatment Price by Type

5 Market Size by Application
    5.1 Overview
    5.2 Global Acquired hemophilia A Treatment Sales by Application

6 United States
   6.1 United States Acquired hemophilia A Treatment Breakdown Data by Company
   6.2 United States Acquired hemophilia A Treatment Breakdown Data by Type
   6.3 United States Acquired hemophilia A Treatment Breakdown Data by Application

7 European Union
   7.1 European Union Acquired hemophilia A Treatment Breakdown Data by Company
   7.2 European Union Acquired hemophilia A Treatment Breakdown Data by Type
   7.3 European Union Acquired hemophilia A Treatment Breakdown Data by Application

8 China
   8.1 China Acquired hemophilia A Treatment Breakdown Data by Company
   8.2 China Acquired hemophilia A Treatment Breakdown Data by Type
   8.3 China Acquired hemophilia A Treatment Breakdown Data by Application

9 Rest of World
    9.1 Rest of World Acquired hemophilia A Treatment Breakdown Data by Company
    9.2 Rest of World Acquired hemophilia A Treatment Breakdown Data by Type
    9.3 Rest of World Acquired hemophilia A Treatment Breakdown Data by Application
    9.4 Rest of World Acquired hemophilia A Treatment Breakdown Data by Countries
        9.4.1 Rest of World Acquired hemophilia A Treatment Sales by Countries
        9.4.2 Rest of World Acquired hemophilia A Treatment Revenue by Countries
        9.4.3 Japan
        9.4.4 Korea
        9.4.5 India
        9.4.6 Southeast Asia

10 Company Profiles
    10.1 Sanofi
        10.1.1 Sanofi Company Details
        10.1.2 Company Description and Business Overview
        10.1.3 Sales, Revenue and Market Share of Acquired hemophilia A Treatment
        10.1.4 Acquired hemophilia A Treatment Product Introduction
        10.1.5 Sanofi Recent Development

11 Value Chain and Sales Channels Analysis
    11.1 Value Chain Analysis
    11.2 Sales Channels Analysis
        11.2.1 Acquired hemophilia A Treatment Sales Channels
        11.2.2 Acquired hemophilia A Treatment Distributors
    11.3 Acquired hemophilia A Treatment Customers

12 Market Forecast
    12.1 Global Acquired hemophilia A Treatment Sales and Revenue Forecast 2019-2025
    12.2 Global Acquired hemophilia A Treatment Sales Forecast by Type
    12.3 Global Acquired hemophilia A Treatment Sales Forecast by Application
    12.4 Acquired hemophilia A Treatment Forecast by Regions
        12.4.1 Global Acquired hemophilia A Treatment Sales Forecast by Regions 2019-2025
        12.4.2 Global Acquired hemophilia A Treatment Revenue Forecast by Regions 2019-2025
    12.5 United States Market Forecast
    12.6 European Union Market Forecast
    12.7 China Market Forecast
    12.8 Rest of World
        12.8.1 Japan
        12.8.2 Korea
        12.8.3 India

13 Research Findings and Conclusion

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
            14.1.1.1 Research Programs/Design
            14.1.1.2 Market Size Estimation
            14.1.1.3 Market Breakdown and Data Triangulation
        14.1.2 Data Source
            14.1.2.1 Secondary Sources
            14.1.2.2 Primary Sources
    14.2 Author Details
    14.3 Disclaimer

List of Tables and Figures Figure Acquired hemophilia A Treatment Product Picture Table Acquired hemophilia A Treatment Key Market Segments Table Major Manufacturers Acquired hemophilia A Treatment Covered in This Report Table Global Acquired hemophilia A Treatment Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Acquired hemophilia A Treatment Sales Market Shar by Type 2014-2025 Figure 200IU Figures Table Major Manufacturers of 200IU Figure 250IU Figures Table Major Manufacturers of 250IU Table Global Acquired hemophilia A Treatment Market Share by Application 2019-2025 (K Units) Figure Hospital Use Case Figure Pharmacy Use Case Figure Acquired hemophilia A Treatment Report Years Considered Figure Global Acquired hemophilia A Treatment Market Size 2014-2025 (Million US$) Figure Global Acquired hemophilia A Treatment Sales 2014-2019 (K Units) Table Global Acquired hemophilia A Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Acquired hemophilia A Treatment Sales by Regions 2014-2019 (K Units) Table Global Acquired hemophilia A Treatment Sales Market Share by Regions 2014-2019 Figure Global Acquired hemophilia A Treatment Sales Market Share by Regions 2014-2019 Figure Global Acquired hemophilia A Treatment Sales Market Share by Regions in 2019 Table Global Acquired hemophilia A Treatment Revenue by Regions 2014-2019 (Million US$) Table Global Acquired hemophilia A Treatment Revenue Market Share by Regions 2014-2019 Figure Global Acquired hemophilia A Treatment Revenue Market Share by Regions 2014-2019 Figure Global Acquired hemophilia A Treatment Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Acquired hemophilia A Treatment Sales by Manufacturers (2014-2019) (K Units) Table Global Acquired hemophilia A Treatment Sales Share by Manufacturers (2014-2019) Figure Global Acquired hemophilia A Treatment Sales Share by Manufacturers in 2019 Table Acquired hemophilia A Treatment Revenue by Manufacturers (2014-2019) (Million USD) Table Acquired hemophilia A Treatment Revenue Share by Manufacturers (2014-2019) Figure Acquired hemophilia A Treatment Value Share by Manufacturers in 2019 Table Global Acquired hemophilia A Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Acquired hemophilia A Treatment Price (2014-2019) (USD/Unit) Table Key Manufacturers Acquired hemophilia A Treatment Plants/Factories Distribution Table Key Manufacturers Acquired hemophilia A Treatment Area Served Table Date of Key Manufacturers Enter into Acquired hemophilia A Treatment Market Table Key Manufacturers Acquired hemophilia A Treatment Product Type Table Mergers & Acquisitions, Expansion Plans Table Global 200IU Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global 250IU Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Acquired hemophilia A Treatment Sales by Type (2014-2019) (K Units) Table Global Acquired hemophilia A Treatment Sales Share by Type (2014-2019) Figure Global Acquired hemophilia A Treatment Sales Market Share by Type (2014-2019) Figure Global Acquired hemophilia A Treatment Sales Market Share by Type in 2018 Table Global Acquired hemophilia A Treatment Revenue by Type (2014-2019) (Million US$) Table Global Acquired hemophilia A Treatment Revenue Share by Type (2014-2019) Figure Global Acquired hemophilia A Treatment Revenue Market Share by Type (2014-2019) Figure Global Acquired hemophilia A Treatment Revenue Market Share by Type in 2018 Table Acquired hemophilia A Treatment Price by Type 2014-2019 (USD/Unit) Table Global Acquired hemophilia A Treatment Sales by Application (2014-2019) (K Units) Table Global Acquired hemophilia A Treatment Sales Share by Application (2014-2019) Figure Global Sales Acquired hemophilia A Treatment Market Share by Application (2014-2019) Figure Global Sales Acquired hemophilia A Treatment Market Share by Application (2014-2019) Figure United States Acquired hemophilia A Treatment Sales Growth Rate 2014-2019 (K Units) Figure United States Acquired hemophilia A Treatment Revenue Growth Rate 2014-2019 (Million US$) Table United States Acquired hemophilia A Treatment Sales by Company (2014-2019) (K Units) Table United States Acquired hemophilia A Treatment Sales Market Share by Company (2014-2019) Figure United States Acquired hemophilia A Treatment Sales Market Share by Company in 2019 Table United States Acquired hemophilia A Treatment Sales by Type (2014-2019) (K Units) Table United States Acquired hemophilia A Treatment Sales Market Share by Type (2014-2019) Figure United States Acquired hemophilia A Treatment Market Share by Type in 2019 Table United States Acquired hemophilia A Treatment Sales by Application (2014-2019) (K Units) Table United States Acquired hemophilia A Treatment Sales Market Share by Application (2014-2019) Figure United States Acquired hemophilia A Treatment Market Share by Application in 2019 Figure European Union Acquired hemophilia A Treatment Sales Growth Rate 2014-2019 (K Units) Figure European Union Acquired hemophilia A Treatment Revenue Growth Rate 2014-2019 (Million US$) Table European Union Acquired hemophilia A Treatment Sales by Company (2014-2019) (K Units) Table European Union Acquired hemophilia A Treatment Sales Market Share by Company (2014-2019) Figure European Union Acquired hemophilia A Treatment Sales Market Share by Company in 2019 Table European Union Acquired hemophilia A Treatment Sales by Type (2014-2019) (K Units) Table European Union Acquired hemophilia A Treatment Sales Market Share by Type (2014-2019) Figure 2018 European Union Acquired hemophilia A Treatment Market Share by Type Table European Union Acquired hemophilia A Treatment Sales by Application (2014-2019) (K Units) Table European Union Acquired hemophilia A Treatment Sales Market Share by Application (2014-2019) Figure 2018 European Union Acquired hemophilia A Treatment Market Share by Application Figure China Acquired hemophilia A Treatment Sales Growth Rate 2014-2019 (K Units) Figure China Acquired hemophilia A Treatment Revenue Growth Rate 2014-2019 (Million US$) Table China Acquired hemophilia A Treatment Sales by Company (2014-2019) (K Units) Table China Acquired hemophilia A Treatment Sales Market Share by Company (2014-2019) Figure China Acquired hemophilia A Treatment Sales Market Share by Company in 2019 Table China Acquired hemophilia A Treatment Sales by Type (2014-2019) (K Units) Table China Acquired hemophilia A Treatment Sales Market Share by Type (2014-2019) Figure China Acquired hemophilia A Treatment Market Share by Type in 2019 Table China Acquired hemophilia A Treatment Sales by Application (2014-2019) (K Units) Table China Acquired hemophilia A Treatment Sales Market Share by Application (2014-2019) Figure China Acquired hemophilia A Treatment Market Share by Application in 2019 Figure Rest of World Acquired hemophilia A Treatment Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Acquired hemophilia A Treatment Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Acquired hemophilia A Treatment Sales by Company (2014-2019) (K Units) Table Rest of World Acquired hemophilia A Treatment Sales Market Share by Company (2014-2019) Figure Rest of World Acquired hemophilia A Treatment Sales Market Share by Company in 2019 Table Rest of World Acquired hemophilia A Treatment Sales by Type (2014-2019) (K Units) Table Rest of World Acquired hemophilia A Treatment Sales Market Share by Type (2014-2019) Figure Rest of World Acquired hemophilia A Treatment Market Share by Type in 2019 Table Rest of World Acquired hemophilia A Treatment Sales by Application (2014-2019) (K Units) Table Rest of World Acquired hemophilia A Treatment Sales Market Share by Application (2014-2019) Figure Rest of World Acquired hemophilia A Treatment Market Share by Application in 2019 Table Rest of World Acquired hemophilia A Treatment Sales by Countries (2014-2019) (K Units) Table Rest of World Acquired hemophilia A Treatment Sales Market Share by Countries (2014-2019) Figure Rest of World Acquired hemophilia A Treatment Sales Market Share by Countries in 2019 Table Rest of World Acquired hemophilia A Treatment Revenue by Countries (2014-2019) (Million US$) Table Rest of World Acquired hemophilia A Treatment Revenue Market Share by Countries (2014-2019) Figure Rest of World Acquired hemophilia A Treatment Revenue Market Share by Countries in 2019 Figure Japan Acquired hemophilia A Treatment Sales Growth Rate (2014-2019) (K Units) Figure Japan Acquired hemophilia A Treatment Revenue Growth Rate (2014-2019) (K Units) Figure Korea Acquired hemophilia A Treatment Sales Growth Rate (2014-2019) (K Units) Figure Korea Acquired hemophilia A Treatment Revenue Growth Rate (2014-2019) (K Units) Figure India Acquired hemophilia A Treatment Sales Growth Rate (2014-2019) (K Units) Figure India Acquired hemophilia A Treatment Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Acquired hemophilia A Treatment Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Acquired hemophilia A Treatment Revenue Growth Rate (2014-2019) (K Units) Table Sanofi Company Details Table Sanofi Description and Business Overview Table Sanofi Acquired hemophilia A Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Sanofi Acquired hemophilia A Treatment Sales Growth Rate (2014-2019) Table Sanofi Acquired hemophilia A Treatment Sales Market Share in Global Market Table Sanofi Recent Development Figure Acquired hemophilia A Treatment Value Chain Table Acquired hemophilia A Treatment Distributors List Table Acquired hemophilia A Treatment Customers List Table Global Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Table Global Acquired hemophilia A Treatment Sales Forecast by Type 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Forecast by Type 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Market Share Forecast by Type 2019-2025 Table Global Acquired hemophilia A Treatment Sales Forecast by Application 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Forecast by Application 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Market Share Forecast by Application 2019-2025 Table Global Acquired hemophilia A Treatment Sales Forecast by Regions 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Forecast by Regions 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Sales Market Share Forecast by Regions 2019-2025 Table Global Acquired hemophilia A Treatment Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Acquired hemophilia A Treatment Revenue Market Share Forecast by Regions 2019-2025 Figure United States Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure United States Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure European Union Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure European Union Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure China Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure China Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure Japan Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure Japan Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure Korea Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure Korea Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure India Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure India Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Acquired hemophilia A Treatment Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Acquired hemophilia A Treatment Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global (United States, European Union and China) Molybdenum Disilicide Heating Element Market Research Report 2019-2025

Molybdenum Disilicide (MoSi2) Heating Element is resistive heating elements based on molybdenum disilicide. The molybdenum disilicide heating elements prevents the inner core from oxidation by forming a compact quartz glass coating at the surface und...

Global (United States, European Union and China) Mobile Phone Memory Market Research Report 2019-2025

Mobile phones have different types of memory in it for different applications, they are RAM and ROM. Flash memory is an electronic (solid-state) non-volatile computer storage medium that can be electrically erased and reprogrammed. In 2019, the mar...

Global (United States, European Union and China) Grid Scale Battery Market Research Report 2019-2025

Grid-scale is defined here as systems over 1 MW in rated power, typically operated by a utility, independent power producer, or Independent System Operator (ISO). The increase in demand for renewable energy, government regulations, and technological...

Global (United States, European Union and China) Fluoroscopy Devices Market Research Report 2019-2025

Fluoroscopy is an imaging technique that uses X-rays to produce real-time images of internal organs. Increasing areas of application and use of fluoroscopy in the pain management are some of the other factors contributing to the market growth. In 2...

Global (United States, European Union and China) Fluidized Bed Gasifier Market Research Report 2019-2025

The Fluid-Bed Gasifier (FBG) converts solid fuels into a syngas consisting mainly of hydrogen and carbon monoxide, which can be further processed to produce a synthetic natural gas or to produce liquid fuels via the Fischer?Tropsch (FT) process. The ...

New Pharmaceuticals and Healthcare Reports